Innovent Biologics (1801N) Earnings Dates, Call Summary & Reports

The P/E ratio of {name} is N/A.

1 Followers

Earnings Data

Report Date

Aug 25, 2026

TBA (Confirmed)

Period Ending

2026 (Q2)

Consensus EPS Forecast

1.18

Last Year’s EPS

1.28

Same Quarter Last Year

Strong Buy

Based on 13 Analysts Ratings

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

MX:1801N Upcoming Earnings

Innovent Biologics's next earnings date is estimated for August 25, 2026, based on past reporting schedules.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Aug 25, 2026	2026 (Q2)	1.18 / -	1.284	―	―	―
Mar 26, 2026	2025 (Q4)	0.30 / -0.03	0.453	-105.56% (-0.48)		―
Aug 27, 2025	2025 (Q2)	0.45 / 1.28	-0.604	312.50% (+1.89)		―
Mar 26, 2025	2024 (Q4)	-0.58 / 0.45	-1.43	131.69% (+1.88)		―
Aug 28, 2024	2024 (Q2)	-0.63 / -0.60	-0.227	-166.67% (-0.38)		―
Mar 20, 2024	2023 (Q4)	-1.76 / -1.43	-2.114	32.38% (+0.68)		―
Aug 23, 2023	2023 (Q2)	-1.69 / -0.23	-1.636	86.15% (+1.41)	―	―
Mar 31, 2023	2022 (Q4)	-1.66 / -2.11	-3.398	37.78% (+1.28)	―	―
Aug 25, 2022	2022 (Q2)	-17.26 / -1.64	-2.039	19.75% (+0.40)	―	―
Mar 29, 2022	2021 (Q4)	-15.39 / -3.40	-0.705	-382.14% (-2.69)	―	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

When does Innovent Biologics (MX:1801N) report earnings?

Innovent Biologics (MX:1801N) is schdueled to report earning on Aug 25, 2026, TBA (Confirmed).

What is Innovent Biologics (MX:1801N) earnings time?

Innovent Biologics (MX:1801N) earnings time is at Aug 25, 2026, TBA (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is the P/E ratio of Innovent Biologics stock?

The P/E ratio of Innovent Biologics is N/A.

What is MX:1801N EPS forecast?

MX:1801N EPS forecast for the fiscal quarter 2026 (Q2) is 1.18.